help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swaisgood, C. M.
Right arrow Articles by Ploplis, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swaisgood, C. M.
Right arrow Articles by Ploplis, V. A.
(American Journal of Pathology. 2000;157:177-187.)
© 2000 American Society for Investigative Pathology


Regular Articles

The Development of Bleomycin-Induced Pulmonary Fibrosis in Mice Deficient for Components of the Fibrinolytic System

Carmen M. Swaisgood*, Esther L. French*, Chris Noga{dagger}, Richard H. Simon{ddagger} and Victoria A. Ploplis§

From the Joseph J. Jacobs Center for Thrombosis and Vascular Biology and the Department of Molecular Cardiology*
and the Department of Anatomic Pathology,{dagger}
Cleveland Clinic Foundation, Cleveland, Ohio; the Department of Internal Medicine,{ddagger}
Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan; and the W. M. Keck Center for Transgene Research and the Department of Chemistry and Biochemistry,§
University of Notre Dame, Notre Dame, Indiana

Acute and chronic pulmonary diseases are characterized by impaired fibrinolytic activity within the lung. To determine the role of the fibrinolytic system in regulating the pathologies associated with lung injury, we examined the effect of bleomycin, an agent that induces the development of pulmonary fibrosis, in mice deficient for plasminogen (Pg-/-), urokinase (u-PA-/-), urokinase receptor (u-PAR-/-), or tissue plasminogen activator (t-PA-/-), and in control wild-type (WT) mice. Pg-/- and t-PA-/- mice demonstrated an enhanced increase in lung collagen content relative to that observed in WT mice. Levels in u-PA-/- and u-PAR-/- mice were similar to those in WT mice. Histological analysis 14 days after lung injury confirmed enhanced interstitial fibrosis in Pg-/-, u-PA-/-, and t-PA-/- mice relative to WT and u-PAR-/- mice. Areas of pulmonary hemorrhage were observed in bleomycin-treated WT mice and not in Pg-/-, u-PA-/-, and u-PAR-/- mice or saline controls. Instead, extensive areas of fibrosis were present throughout the lungs of bleomycin-treated Pg-/- and u-PA-/- mice. A mixed phenotype (hemorrhage and fibrosis) was observed in t-PA-/- and Pg+/- mice. Hemosiderin-laden macrophages were abundant in the lungs of mice exhibiting hemorrhage and these mice were prone to an early death. Enhanced macrophage levels in the lungs and activation of matrix metalloelastase (MMP-12) were found in mice with a hemorrhage phenotype. The results of these studies indicate a role for the fibrinolytic system in acute lung injury and suggests that intra-alveolar hemorrhage is the result of basement membrane degradation through cell-mediated u-PA activation of Pg with possible involvement of matrix metalloproteinases. Absence of these two components of the fibrinolytic system, either urokinase or plasminogen, results in accelerated fibrosis.





This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Zhu, C. L. Gladson, K. E. White, Q. Ding, J. Stewart Jr., T. H. Jin, H. A. Chapman Jr., and M. A. Olman
Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins
Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L97 - L108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Kuramoto, T. Nishiuma, K. Kobayashi, M. Yamamoto, Y. Kono, Y. Funada, Y. Kotani, T. H. Sisson, R. H. Simon, and Y. Nishimura
Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L337 - L346.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Shetty, J. Padijnayayveetil, T. Tucker, D. Stankowska, and S. Idell
The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L967 - L975.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. Shetty, T. Velusamy, Y. P. Bhandary, R. S. Shetty, M.-C. Liu, and S. Shetty
Urokinase Expression by Tumor Suppressor Protein p53: A Novel Role in mRNA Turnover
Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 364 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Bryer, G. Fantuzzi, N. Van Rooijen, and T. J. Koh
Urokinase-Type Plasminogen Activator Plays Essential Roles in Macrophage Chemotaxis and Skeletal Muscle Regeneration
J. Immunol., January 15, 2008; 180(2): 1179 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Shetty, T. Velusamy, S. Idell, P. Shetty, A. P. Mazar, Y. P. Bhandary, and R. S. Shetty
Regulation of Urokinase Receptor Expression by p53: Novel Role in Stabilization of uPAR mRNA
Mol. Cell. Biol., August 15, 2007; 27(16): 5607 - 5618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. M. Swaisgood, M. A. Aronica, S. Swaidani, and E. F. Plow
Plasminogen Is an Important Regulator in the Pathogenesis of a Murine Model of Asthma
Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 333 - 342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Cosgrove
A complex, tissue-specific role for plasmin and its regulators in modulating fibrogenic activity
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F10 - F11.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Shetty, T. Velusamy, S. Idell, H. Tang, and P. K. Shetty
Regulation of urokinase receptor expression by protein tyrosine phosphatases
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L414 - L421.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Matsuoka, T. H. Sisson, T. Nishiuma, and R. H. Simon
Plasminogen-Mediated Activation and Release of Hepatocyte Growth Factor from Extracellular Matrix
Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. A. Eddy and A. B. Fogo
Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2999 - 3012.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. J. Tan, C. L. Fattman, L. M. Niehouse, J. M. Tobolewski, L. E. Hanford, Q. Li, F. A. Monzon, W. C. Parks, and T. D. Oury
Matrix Metalloproteinases Promote Inflammation and Fibrosis in Asbestos-Induced Lung Injury in Mice
Am. J. Respir. Cell Mol. Biol., September 1, 2006; 35(3): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Fujimoto, E. C. Gabazza, O. Taguchi, Y. Nishii, H. Nakahara, N. E. Bruno, C. N. D'Alessandro-Gabazza, M. Kasper, Y. Yano, M. Nagashima, et al.
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis
Am. J. Pathol., April 1, 2006; 168(4): 1086 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. H. Kim, H. Y. Kim, S. Kim, J.-H. Chung, W. S. Park, and D. H. Chung
Natural Killer T (NKT) Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis by Producing Interferon-{gamma}
Am. J. Pathol., November 1, 2005; 167(5): 1231 - 1241.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Cheng, Y. Zhao, W. E. Lawson, V. V. Polosukhin, J. E. Johnson, T. S. Blackwell, and D. Gailani
The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice
Blood, November 1, 2005; 106(9): 3055 - 3057.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. de Giorgio-Miller, S. Bottoms, G. Laurent, P. Carmeliet, and S. Herrick
Fibrin-Induced Skin Fibrosis in Mice Deficient in Tissue Plasminogen Activator
Am. J. Pathol., September 1, 2005; 167(3): 721 - 732.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. D. Weisberg, F. Albornoz, J. P. Griffin, D. L. Crandall, H. Elokdah, A. B. Fogo, D. E. Vaughan, and N. J. Brown
Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 Attenuates Angiotensin II/Salt-Induced Aortic Remodeling
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 365 - 371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. H. Lazar, P. J. Christensen, M. Du, B. Yu, N. M. Subbotina, K. E. Hanson, J. M. Hansen, E. S. White, R. H. Simon, and T. H. Sisson
Plasminogen Activator Inhibitor-1 Impairs Alveolar Epithelial Repair by Binding to Vitronectin
Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 672 - 678.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Nishiuma, T. H. Sisson, N. Subbotina, and R. H. Simon
Localization of Plasminogen Activator Activity within Normal and Injured Lungs by In Situ Zymography
Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 552 - 558.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Buhling, C. Rocken, F. Brasch, R. Hartig, Y. Yasuda, P. Saftig, D. Bromme, and T. Welte
Pivotal Role of Cathepsin K in Lung Fibrosis
Am. J. Pathol., June 1, 2004; 164(6): 2203 - 2216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Hattori, S. Mizuno, Y. Yoshida, K. Chin, M. Mishima, T. H. Sisson, R. H. Simon, T. Nakamura, and M. Miyake
The Plasminogen Activation System Reduces Fibrosis in the Lung by a Hepatocyte Growth Factor-Dependent Mechanism
Am. J. Pathol., March 1, 2004; 164(3): 1091 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Chuang-Tsai, T. H. Sisson, N. Hattori, C. G. Tsai, N. M. Subbotina, K. E. Hanson, and R. H. Simon
Reduction in Fibrotic Tissue Formation in Mice Genetically Deficient in Plasminogen Activator Inhibitor-1
Am. J. Pathol., August 1, 2003; 163(2): 445 - 452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Fujimoto, E. C. Gabazza, O. Hataji, H. Yuda, C. N. D'Alessandro-Gabazza, M. Nakano, O. E. Franco, T. Hayashi, K. Suzuki, Y. Adachi, et al.
Thrombin-activatable Fibrinolysis Inhibitor and Protein C Inhibitor in Interstitial Lung Disease
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1687 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, P. Carmeliet, and A. A. Eddy
Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1234 - 1253.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, C. E. Alpers, Y. Liu, P. Carmeliet, and A. A. Eddy
Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy
J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1254 - 1271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Jakubzick, E. S. Choi, S. L. Kunkel, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
Impact of Interleukin-13 Responsiveness on the Synthetic and Proliferative Properties of Th1- and Th2-Type Pulmonary Granuloma Fibroblasts
Am. J. Pathol., May 1, 2003; 162(5): 1475 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T.-L. Tuan, H. Wu, E. Y. Huang, S. S. N. Chong, W. Laug, D. Messadi, P. Kelly, and A. Le
Increased Plasminogen Activator Inhibitor-1 in Keloid Fibroblasts May Account for their Elevated Collagen Accumulation in Fibrin Gel Cultures
Am. J. Pathol., May 1, 2003; 162(5): 1579 - 1589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. H. Sisson, K. E. Hanson, N. Subbotina, A. Patwardhan, N. Hattori, and R. H. Simon
Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1023 - L1032.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. A. Ploplis, J. Wilberding, L. McLennan, Z. Liang, I. Cornelissen, M. E. DeFord, E. D. Rosen, and F. J. Castellino
A Total Fibrinogen Deficiency Is Compatible with the Development of Pulmonary Fibrosis in Mice
Am. J. Pathol., September 1, 2000; 157(3): 703 - 708.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.